BENZODIAZEPINE OVERINDULGENCE AND DRUG INTERACTIONS
BENZODIAZEPINE OVERINDULGENCE AND DRUG INTERACTIONS
批准号:
6174589
负责人:
CHYAN E LAU
金额:
$26.52万
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-01-15 至 2001-06-30
关键词:
albino rat alprazolam behavior test behavioral /social science research tag benzodiazepines blood chemistry caffeine drug abuse drug adverse effect drug interactions drug tolerance high performance liquid chromatography inhibitor /antagonist midazolam oral administration pharmacokinetics psychomotor function reinforcer substance abuse related behavior theophylline tremor water drinking behavior
中文摘要
(1)苯二氮卓类药物口服强化疗效的启动
(BZs)将在动物中研究滥用摄入水平,
在时间表诱导的烦渴条件下的偏好程序。 一
可能降低口腔BZ的强化阈值,
精神兴奋剂,特别是咖啡因,
BZ拮抗剂氟马西尼,以及血清药代动力学相关
对口服BZ的补益作用进行研究。 (2)的协同
咪达唑仑和咖啡因联合注射在干扰细-
运动任务的表现将使用各种自发的
和编程的运动测量。 这些研究可能暗示咖啡因
(and其他兴奋剂)在老年人的运动问题(特别是
下降),涉及BZ和不能还原为BZ镇静作用。
BZ-黄嘌呤协同作用的行为学和药理学共性
将被定性。 (3)增加的行为影响
在血清咖啡因的表观清除率中,
将探讨咪达唑仑暴露的可能性,
BZ停药综合征可归因于咖啡因中毒。 (四)
BZ-兴奋剂的急性和慢性药代动力学说明
组合将平行的行为研究,在划定的
BZ-黄嘌呤协同作用的机理。 (5)将有一项研究,
阿普唑仑-咖啡因相互作用可能的协同破坏
精细运动控制,这可能与触发或
恐慌症恶化 此外,BZ对茶碱的作用
将注意到行为效应与
治疗剂量的茶碱,特别是通过口服途径。
英文摘要
(1) The initiation of oral reinforcing efficacy for benzodiazepines
(BZs) will be studied in animals at abusive intake levels using a drug
preference procedure under schedule-induced polydipsia conditions. A
possible decrease in the reinforcing threshold of oral BZs by
psychomotor stimulants, particularly caffeine, a threshold shift by the
BZ antagonist flumazenil, as well as the serum pharmacokinetics relevant
to oral BZ reinforcing function, will be studied. (2) The synergistic
action of combined midazolam and caffeine injections in disrupting fine-
motor task performance will be analyzed using a variety of spontaneous
and programmed motor measures. These studies may implicate caffeine
(and other stimulants) in motor problems of the elderly (specifically
falling) that involve BZs and are not reducible to BZ sedative action.
The behavioral and pharmacologic generality of BZ-xanthine synergism
will be characterized. (3) The behavioral implications of the increase
in apparent clearance of serum caffeine that results from chronic
exposure to midazolam will be explored with the possibility that part of
the BZ discontinuance syndrome may be attributable to caffeinism. (4)
Clarification of the acute and chronic pharmacokinetics of BZ-stimulant
combinations will parallel behavioral studies in the delineation of the
mechanism of BZ-xanthine synergism. (5) There will be study of a
alprazolam-caffeine interactions for a possible synergistic disruption
of fine-motor control, which might be relevant to triggering or
worsening panic disorder. Also, the effect of BZs on theophylline's
behavioral effects will be noted in relation to tremor produced by
therapeutic doses of theophylline, particularly by the oral route.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Motor performance decrement by midazolam: antagonism by Ro 15-1788 and CGS 8216.
咪达唑仑导致的运动表现下降:Ro 15-1788 和 CGS 8216 的拮抗作用。
DOI:
10.1016/0091-3057(90)90139-9
发表时间:
1990
期刊:
Pharmacology, biochemistry, and behavior
影响因子:
--
作者:
[Lau,CE, Falk,JL, Tang,M]
通讯作者:
Tang,M
Midazolam-induced increase in NaCl solution ingestion: differential effect of the benzodiazepine antagonists Ro 15-1788 and CGS 8216.
咪达唑仑诱导的 NaCl 溶液摄入量增加:苯二氮卓类拮抗剂 Ro 15-1788 和 CGS 8216 的不同作用。
DOI:
10.1016/s0091-3057(84)80081-7
发表时间:
1984
期刊:
Pharmacology, biochemistry, and behavior
影响因子:
--
作者:
[Falk,JL, Tang,M]
通讯作者:
Tang,M
Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics.
阿普唑仑、咖啡因及其相互作用:将 DRL 性能与药代动力学联系起来。
DOI:
10.1007/bf02246346
发表时间:
1996
期刊:
Psychopharmacology
影响因子:
3.4
作者:
[Lau,CE, Wang,J]
通讯作者:
Wang,J
The role of central- and peripheral-type benzodiazepine receptors in anxiolytic-agent augmentation of NaCl solution intake: effects of clonazepam and Ro 5-4864.
中枢型和外周型苯二氮卓受体在抗焦虑剂增加氯化钠溶液摄入量中的作用:氯硝西泮和 Ro 5-4864 的作用。
DOI:
10.1016/0091-3057(88)90093-7
发表时间:
1988
期刊:
Pharmacology, biochemistry, and behavior
影响因子:
--
作者:
[Tang,M, Plaessmann,WR, Falk,JL]
通讯作者:
Falk,JL
Chlordiazepoxide injection elevates the NaCl solution acceptance-rejection function.
利眠宁注射液可提高 NaCl 溶液的接受-排斥功能。
DOI:
10.1016/s0091-3057(84)80108-2
发表时间:
1984
期刊:
Pharmacology, biochemistry, and behavior
影响因子:
--
作者:
[Falk,JL, Tang,M]
通讯作者:
Tang,M
共 24 条
STIMULANT ABUSE BEHAVIOR AND PHARMACOKINETICS
-
批准号:6193991
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2000
-
负责人:CHYAN E LAU
-
依托单位:
COCAINE, CAFFEINE AND NICOTINE--ORAL ABUSE AND BEHAVIOR
-
批准号:6124921
-
项目类别:
-
资助金额:$22.42万
-
财政年份:1987
-
负责人:CHYAN E LAU
-
依托单位:
海外基金